Celldex Therapeutics, Inc.
CLDX
Revenue
1.18M
▼-2.02M▼-63.18%
3 Months ChangeAssets
792.34M
▼-30.84M▼-3.75%
3 Months ChangeLiabilities
45.34M
▲8.06M▲21.63%
3 Months ChangeFree Cash Flow
-40.98M
▼-11.83M▼-40.57%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-08
Form 10-Q
ID: 0001410578-24-001219
2024-08-08
Form 8-K
ID: 0001171843-24-004603
2024-06-14
Form 8-K
ID: 0001104659-24-071512
2024-05-06
Form 10-Q
ID: 0001410578-24-000593
2024-05-06
Form 8-K
ID: 0001171843-24-002570
2024-03-01
Form 8-K
ID: 0001104659-24-029969
2024-02-26
Form 8-K
ID: 0001171843-24-000966
2023-11-08
Form 8-K
ID: 0001104659-23-115796
2023-11-06
Form 8-K
ID: 0001104659-23-114520
2023-11-02
Form 10-Q
ID: 0001410578-23-002169